Summary by Moomoo AI
Lucas Montarce, the EVP & CFO of Eli Lilly and Co, has filed an initial statement of beneficial ownership with the SEC, disclosing the direct ownership of 10,467 shares of common stock. The filing, made pursuant to Section 16(a) of the Securities Exchange Act of 1934, was submitted on 09/18/2024 following the event date of 09/09/2024. Additionally, Montarce holds restricted stock units (RSUs) that represent a contingent right to receive shares of Eli Lilly common stock upon vesting. The RSUs are set to vest on various dates, with the earliest being 11/01/2024 and the latest on 02/16/2027. The filing indicates that Montarce's ownership is direct, and it includes a power of attorney executed by Jonathan Groff on behalf of Montarce.
